Dow (DOW) Q1 2026 Earnings Call Transcript

Dow reported Q1 net sales of $9.8 billion, operating EBITDA of $873 million, and $193 million of period cost savings, while guiding Q2 to about $12 billion of revenue and $2 billion of EBITDA. Management said Middle East supply disruptions are tightening polyethylene and related markets, supporting price increases and margin expansion, with April’s $0.30/lb polyethylene increase included in guidance and May’s $0.20/lb hike offering upside. The company also highlighted over $4 billion of cash, $14 billion of liquidity, and a leadership transition with Karen S. Carter becoming CEO on July 1, 2026.

Analysis

The market is likely underestimating how much of Dow’s near-term earnings power is now being driven by a supply shock rather than a cyclical demand recovery. That matters because supply-driven margin expansion tends to be stickier than consensus models assume: when global logistics are impaired, product can’t normalize simply because end demand softens for a quarter. The second-order effect is that Dow’s cost-advantaged Americas footprint and feedstock flexibility become a relative earnings hedge versus peers with more Europe/Middle East exposure, while any producer that depends on merchant imports, naphtha economics, or Asian arbitrage should see a slower and noisier recovery.

The more interesting setup is that management is explicitly guiding only the April leg of pricing into Q2, while still signaling additional upside from May. That creates a clean “guidance gap” for the next earnings prints: if pricing holds, EBITDA revisions should continue to move higher without requiring incremental volume growth. The risk is not a quick reversion in commodity prices; it is a policy/logistics unwind that restores shipping flows faster than physical plants, which would compress spreads before headline supply looks normal. In that scenario, Europe likely loses margin first, but the real casualty is any long-duration earnings multiple expansion built on peak-style polyethylene assumptions.

A separate underappreciated angle is capital allocation. With limited near-term capex and a balance sheet that appears structurally de-risked, incremental cash flow will likely be deployed to buybacks or balance-sheet flexibility rather than growth, increasing per-share torque if this margin environment persists for multiple quarters. The contrarian view is that consensus may be extrapolating a V-shaped normalization when the bigger variable is not demand destruction, but the sequencing of supply restoration; that favors staying long the spread for months, not days, yet being tactical on duration because the unwind will be abrupt once shipping bottlenecks clear.

Key Decisions for Investors

• Go long DOW common into pullbacks over the next 2-6 weeks; target a multi-quarter re-rating if Q2 pricing holds and May pricing flows through, but size with a hard stop if polyethylene spreads reverse before the next print.
• Pair trade: long DOW / short LYB for the next 1-2 quarters to isolate geopolitical supply tightness and Americas feedstock advantage versus a more globally exposed commodity chemical peer.
• Buy DOW call spreads 3-6 months out rather than outright calls; the setup is earnings-upside driven but the unwind risk is binary, so capped-premium structures fit the risk/reward better.
• Short or underweight European chemical exposure with heavier naphtha dependence for the next 6-12 months; the second-order loser is the high-cost producer that benefits least from logistics dislocation and suffers most on reversal.
• If already long DOW, take partial profits into any sharp post-earnings gap up and keep a trailing hedge; the key risk is not miss on Q2, it is a faster-than-expected supply normalization in 2H26.